GSK3B and Alzheimer disease: Conversely, increased activity of glycogen synthase kinase 3 (GSK3β), which inhibits the LRP6-mediated Wnt-β-catenin signaling, is believed to account for several pathological hallmarks of prion peptide-induced cell death [52]and AD [53, 54].